Key result
Presence of a respiratory virus in plasma or CSF of young febrile infants was associated with a lower rate of serious bacterial infections compared to no virus detected (3% vs. 26%, p=0.008).
Why the study?
Detection of viruses other than enterovirus in the blood and cerebrospinal fluid of febrile infants ≤90 days is not well defined.
What is the occurrence of respiratory viruses in the blood and CSF of young febrile infants?
Cohort (n=126)
What is the occurrence of respiratory viruses in the blood and CSF of young febrile infants?
Absolute Event Rate: 3% vs 26%
p-value: p=0.008
Molecular diagnostics identifying enterovirus and parechovirus in blood specimens can be useful in evaluating febrile infants ≤90 days, as viral positivity is associated with a lower risk of serious bacterial infections.
May inform viral testing in febrile infants; hypothesis-generating for CNS involvement and requires prospective validation.
Background Respiratory viral infections are common in febrile infants ≤90 days. However, the detection of viruses other than enterovirus in the blood and cerebrospinal fluid (CSF) of young infants is not well defined. We sought to quantify the occurrence of respiratory viruses in the blood and CSF of febrile infants ≤90 days. Methods We conducted a nested cohort study examining plasma and CSF samples from febrile infants 15–90 days via rtPCR. The samples were tested for respiratory viruses (respiratory syncytial virus, influenza, enterovirus, parechovirus, adenovirus, bocavirus). Clinical and laboratory data were also collected to determine the presence of serious bacterial infections (SBI). Results Twenty‐four percent (30 of 126) of infants had plasma/CSF specimens positive for a respiratory virus. Enterovirus and parechovirus were the most commonly detected respiratory viruses. Viral positivity was highest in plasma samples at 25% (27 of 107) compared with CSF samples at 15% (nine of 62). SBIs (specifically urinary tract infections) were less common in infants with a sample positive for a respiratory virus compared to those without a virus detected (3% vs. 26%, p = 0.008). Conclusions Our findings support the use of molecular diagnostics to include the identification of parechovirus in addition to enterovirus in febrile infants ≤90 days. Additionally, these data support the utilization of blood specimens to diagnose enterovirus and parechovirus infections in febrile infants ≤90 days.
No takes yet. Share an insight, caveat, or question.
Nicholson et al. (2024) conducted a cohort in Febrile infants (n=126). Presence of respiratory virus vs. No respiratory virus detected was evaluated on Serious bacterial infections (SBI) (p=0.008). Presence of a respiratory virus in plasma or CSF of young febrile infants was associated with a lower rate of serious bacterial infections compared to no virus detected (3% vs. 26%, p=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: